Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 19/20 | 0.51 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25970931 | 1.00 | GLP1R (0.51) | GLP1RPTGER4 | |
| SCHEMBL29149777 | 0.89 | GLP1R (0.50) | GLP1R | |
| SCHEMBL29149774 | 0.89 | GLP1R (0.50) | GLP1R | |
| SCHEMBL20266409 | 0.88 | GLP1R (0.50) | GLP1R | |
| SCHEMBL29098067 | 0.88 | GLP1R (0.50) | GLP1R | |
| SCHEMBL28789072 | 0.88 | GLP1R (0.51) | GLP1R | |
| SCHEMBL24338858 | 0.88 | GLP1R (0.50) | GLP1R | |
| SCHEMBL20266411 | 0.88 | GLP1R (0.50) | GLP1R | |
| SCHEMBL28789071 | 0.88 | GLP1R (0.51) | GLP1R | |
| SCHEMBL27154428 | 0.88 | GLP1R (0.50) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024046342-A1 | BENZO BICYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, AND USE THEREOF | 广州市联瑞制药有限公司 | 2024-03-07 | — | — | WO | disclosed |
| WO-2023169436-A1 | BENZO BICYCLIC COMPOUND, AND PREPARATION METHOD AND APPLICATION THEREOF | 广州市联瑞制药有限公司 | 2023-09-14 | — | — | WO | disclosed |
| US-20220193063-A1 | METABOLITES OF GLP1R AGONISTS | PFIZER INC. (US) | 2022-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193063-A1 | METABOLITES OF GLP1R AGONISTS | GLP1R, GIPR, GCGR | GLP1R 1/4885PTGER4 1603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.